Mizuho’s Irina Rivkind Koffler is leaving the sidelines on Teba and boosting her price target, now angling for 19% upside.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that its subsidiary, Teva Pharmaceuticals International GmbH., has signed a global license agreement with Alder BioPharmaceuticals.
There’s been much ado about Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). The generic drug giant has too much debt and is experiencing pricing …
Though in the next 12 months, Cantor’s Louise Chen is hesitant to take a gamble on an Israeli biotech giant just at the beginning of a comeback, she likes what she sees in new TEVA CEO Kare Schultz’s strategy.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been hit with recent negative sentiment on its home front in Israel, as the company deals …
Is Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) “a ticking bomb” after new Danish CEO Kare Schultz has ordered a quarter of the Israeli …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has secured a priority review at the FDA for its fremanezumab’s BLA for prevention of migraine. Securing a …
This 50 billion-dollar fund is dropping VRX and turning to TEVA.
Mizuho’s Irina Rivkind reflects on how much Teva’s cost cutting compare to expectations; The missing puzzle piece – revenue guidance.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced this morning the exclusive US launch of Viread®1 (tenofovir disoproxil fumarate) tablets 300 mg, a generic …
